MarketPeel
Insider Trading Intelligence
Pricing
…
MR

Michael Raab

FOLD
DIRECTOR · AMICUS THERAPEUTICS, INC. · CIK 0001321402
FILING MIX · LIFETIME35%/65%
BUYS
60
SELLS
112
TOTAL VALUE
$10.95M
COMPANIES
3
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
1,742,096
AVG SELL PX
$5.70
TRADE KIND
SHOWING 172 / 172
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
71 backtested trades · 8 horizons · 49 pending
Forward-return performance of every backtestable P/S trade by Michael Raab, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d71+54.93%+0.17%-0.36%+0.53%-1.33%0.46
14d71+49.30%+1.13%-0.63%+1.76%-0.82%1.14
30d71+52.11%+1.04%-0.29%+1.33%-2.39%0.68
60d71+53.52%+5.35%+2.27%+3.08%-2.58%0.93
90d71(1 pending)+54.29%+7.80%+4.55%+3.31%-7.22%0.67
180d71(8 pending)+60.32%+17.24%+9.09%+8.15%-18.83%0.91
1y71(10 pending)+45.90%+49.87%+19.15%+30.72%-20.92%1.81
2y71(30 pending)+58.54%+146.42%+38.38%+111.84%-48.66%1.95
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
FOLD · 0 shares · as of Apr 27, 2026
028,96457,92986,893115,857202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 60 buys / 112 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ARDX
ARDELYX, INC.
PURCHASE
President & CEO
20,833$0.99$20.6K1,740,866Jun 15, 2026Jun 17, 2026 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
20,833——311,668Jun 15, 2026Jun 17, 2026 ↗View →
ARDX
ARDELYX, INC.
SALE10b5-1
10b5-1 plan
41,666$5.67$236.3K1,699,200Jun 15, 2026Jun 17, 2026 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
17,926$6.27$112.4K1,734,061May 21, 2026May 22, 2026 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
14,933$6.27$93.6K1,759,848May 21, 2026May 22, 2026 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
14,028$6.27$87.9K1,720,033May 21, 2026May 22, 2026 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
7,861$6.27$49.3K1,751,987May 21, 2026May 22, 2026 ↗View →
ARDX
ARDELYX, INC.
SALE10b5-1
10b5-1 plan
41,666$6.28$261.6K1,774,781May 15, 2026May 19, 2026 ↗View →
ARDX
ARDELYX, INC.
PURCHASE
President & CEO
20,833$0.99$20.6K1,816,447May 15, 2026May 19, 2026 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
20,833——332,501May 15, 2026May 19, 2026 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
SALE
36,111——0Apr 27, 2026Apr 27, 2026 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
SALE
16,236——0Apr 27, 2026Apr 27, 2026 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
SALE
42,467——0Apr 27, 2026Apr 27, 2026 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
SALE
19,473——0Apr 27, 2026Apr 27, 2026 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
SALE
45,423——0Apr 27, 2026Apr 27, 2026 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
SALE
115,857$14.50$1.68M0Apr 27, 2026Apr 27, 2026 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
SALE
18,574——0Apr 27, 2026Apr 27, 2026 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
SALE
74,872——0Apr 27, 2026Apr 27, 2026 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
SALE
30,474——0Apr 27, 2026Apr 27, 2026 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
SALE
20,000——0Apr 27, 2026Apr 27, 2026 ↗View →
ARDX
ARDELYX, INC.
PURCHASE
President & CEO
20,834$0.99$20.6K1,837,282Apr 15, 2026Apr 17, 2026 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
20,834——353,334Apr 15, 2026Apr 17, 2026 ↗View →
ARDX
ARDELYX, INC.
SALE10b5-1
10b5-1 plan
41,668$6.29$262.0K1,795,614Apr 15, 2026Apr 17, 2026 ↗View →
ARDX
ARDELYX, INC.
SALE10b5-1
10b5-1 plan
41,666$5.84$243.3K1,816,448Mar 16, 2026Mar 18, 2026 ↗View →
ARDX
ARDELYX, INC.
PURCHASE
President & CEO
20,833$0.99$20.6K1,856,986Mar 16, 2026Mar 18, 2026 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
20,833——374,168Mar 16, 2026Mar 18, 2026 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
20,833——395,001Feb 24, 2026Feb 25, 2026 ↗View →
ARDX
ARDELYX, INC.
PURCHASE
President & CEO
20,833$0.99$20.6K1,877,819Feb 24, 2026Feb 25, 2026 ↗View →
ARDX
ARDELYX, INC.
SALE10b5-1
10b5-1 plan
41,666$6.26$260.6K1,836,153Feb 24, 2026Feb 25, 2026 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
40,401$5.87$237.0K1,862,567Feb 20, 2026Feb 23, 2026 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
2$5.70$111,856,986Feb 20, 2026Feb 23, 2026 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
1$5.70$61,856,988Feb 20, 2026Feb 23, 2026 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
2$5.70$111,856,989Feb 20, 2026Feb 23, 2026 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
5,576$5.71$31.9K1,856,991Feb 20, 2026Feb 23, 2026 ↗View →
TPST
TEMPEST THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
1,230——1,230Jan 27, 2026Jan 28, 2026 ↗View →
ARDX
ARDELYX, INC.
PURCHASEGRANT
Stock grant
446,220——1,902,968Jan 23, 2026Jan 26, 2026 ↗View →
ARDX
ARDELYX, INC.
PURCHASEGRANT
Stock grant
669,330——669,330Jan 23, 2026Jan 26, 2026 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
46,887$5.54$259.6K1,455,363Nov 21, 2025Nov 25, 2025 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
45,687$5.93$271.0K1,502,250Aug 21, 2025Aug 25, 2025 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
20,414——115,857Jun 5, 2025Jun 6, 2025 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
74,872——74,872Jun 5, 2025Jun 6, 2025 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
46,817$4.08$191.1K1,547,937May 20, 2025May 22, 2025 ↗View →
ARDX
ARDELYX, INC.
SALE10b5-1
10b5-1 plan
41,666$4.25$177.2K1,594,754May 2, 2025May 5, 2025 ↗View →
ARDX
ARDELYX, INC.
PURCHASE
President & CEO
20,833$0.99$20.6K1,636,420May 2, 2025May 5, 2025 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
20,833——415,834May 2, 2025May 5, 2025 ↗View →
ARDX
ARDELYX, INC.
SALE10b5-1
10b5-1 plan
41,666$4.59$191.2K1,615,587Apr 4, 2025Apr 8, 2025 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
20,833——436,667Apr 4, 2025Apr 8, 2025 ↗View →
ARDX
ARDELYX, INC.
PURCHASE
President & CEO
20,833$0.99$20.6K1,657,253Apr 4, 2025Apr 8, 2025 ↗View →
ARDX
ARDELYX, INC.
PURCHASE
President & CEO
20,834$0.99$20.6K1,676,806Mar 7, 2025Mar 7, 2025 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
20,834——457,500Mar 7, 2025Mar 7, 2025 ↗View →
ARDX
ARDELYX, INC.
SALE10b5-1
10b5-1 plan
41,668$5.36$223.2K1,635,138Mar 7, 2025Mar 7, 2025 ↗View →
ARDX
ARDELYX, INC.
PURCHASEGRANT
Stock grant
855,326——855,326Feb 25, 2025Feb 27, 2025 ↗View →
ARDX
ARDELYX, INC.
PURCHASEGRANT
Stock grant
570,217——1,655,972Feb 25, 2025Feb 27, 2025 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
22,964$5.62$129.1K1,085,755Feb 20, 2025Feb 21, 2025 ↗View →
ARDX
ARDELYX, INC.
PURCHASE
President & CEO
20,833$0.99$20.6K1,150,385Jan 31, 2025Jan 31, 2025 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
20,833——478,334Jan 31, 2025Jan 31, 2025 ↗View →
ARDX
ARDELYX, INC.
SALE10b5-1
10b5-1 plan
41,666$5.36$223.4K1,108,719Jan 31, 2025Jan 31, 2025 ↗View →
ARDX
ARDELYX, INC.
PURCHASE
President & CEO
20,833$0.99$20.6K1,171,218Jan 7, 2025Jan 10, 2025 ↗View →
ARDX
ARDELYX, INC.
SALE10b5-1
10b5-1 plan
41,666$5.31$221.3K1,129,552Jan 7, 2025Jan 10, 2025 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
20,833——499,167Jan 7, 2025Jan 10, 2025 ↗View →
ARDX
ARDELYX, INC.
PURCHASE
President & CEO
25,000$0.99$24.8K1,175,385Dec 10, 2024Dec 12, 2024 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
25,000——520,000Dec 10, 2024Dec 12, 2024 ↗View →
ARDX
ARDELYX, INC.
SALE10b5-1
10b5-1 plan
25,000$5.26$131.6K1,150,385Dec 10, 2024Dec 12, 2024 ↗View →
ARDX
ARDELYX, INC.
SALE10b5-1
10b5-1 plan
25,000$5.38$134.5K1,150,385Nov 25, 2024Nov 27, 2024 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
31,980$4.79$153.3K1,175,385Nov 20, 2024Nov 22, 2024 ↗View →
ARDX
ARDELYX, INC.
SALE10b5-1
10b5-1 plan
2,743$4.90$13.4K1,207,365Nov 11, 2024Nov 12, 2024 ↗View →
ARDX
ARDELYX, INC.
SALE10b5-1
10b5-1 plan
25,000$5.91$147.7K1,210,108Oct 28, 2024Oct 29, 2024 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
25,000——545,000Oct 28, 2024Oct 29, 2024 ↗View →
ARDX
ARDELYX, INC.
PURCHASE
President & CEO
25,000$0.99$24.8K1,235,108Oct 28, 2024Oct 29, 2024 ↗View →
ARDX
ARDELYX, INC.
SALE10b5-1
10b5-1 plan
7,500$6.01$45.1K1,210,108Oct 11, 2024Oct 15, 2024 ↗View →
ARDX
ARDELYX, INC.
SALE10b5-1
10b5-1 plan
3,000$6.07$18.2K1,217,608Sep 26, 2024Sep 27, 2024 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
35,000$5.61$196.4K1,220,608Sep 11, 2024Sep 13, 2024 ↗View →
ARDX
ARDELYX, INC.
PURCHASE
President & CEO
35,000$0.99$34.6K1,255,608Sep 11, 2024Sep 13, 2024 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
35,000——570,000Sep 11, 2024Sep 13, 2024 ↗View →
ARDX
ARDELYX, INC.
SALE10b5-1
10b5-1 plan
7,500$6.22$46.6K1,219,509Aug 27, 2024Aug 28, 2024 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
32,225$5.86$188.8K1,227,009Aug 20, 2024Aug 22, 2024 ↗View →
ARDX
ARDELYX, INC.
SALE10b5-1
10b5-1 plan
1,229$5.71$7.0K1,259,234Aug 12, 2024Aug 14, 2024 ↗View →
ARDX
ARDELYX, INC.
PURCHASE
President & CEO
30,000$0.99$29.7K1,290,463Jul 29, 2024Jul 31, 2024 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
30,000——605,000Jul 29, 2024Jul 31, 2024 ↗View →
ARDX
ARDELYX, INC.
SALE10b5-1
10b5-1 plan
30,000$5.64$169.3K1,260,463Jul 29, 2024Jul 31, 2024 ↗View →
ARDX
ARDELYX, INC.
SALE10b5-1
10b5-1 plan
7,500$5.97$44.8K1,260,463Jul 15, 2024Jul 17, 2024 ↗View →
ARDX
ARDELYX, INC.
SALE10b5-1
10b5-1 plan
2,310$6.59$15.2K1,267,963Jun 28, 2024Jun 28, 2024 ↗View →
TPST
TEMPEST THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
16,000——16,000Jun 13, 2024Jun 14, 2024 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
35,000——665,000Jun 13, 2024Jun 17, 2024 ↗View →
ARDX
ARDELYX, INC.
SALE10b5-1
10b5-1 plan
35,000$6.65$232.7K1,270,273Jun 13, 2024Jun 17, 2024 ↗View →
ARDX
ARDELYX, INC.
PURCHASE
President & CEO
35,000$0.99$34.6K1,305,273Jun 13, 2024Jun 17, 2024 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
42,467——42,467Jun 6, 2024Jun 7, 2024 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
11,847——95,443Jun 6, 2024Jun 7, 2024 ↗View →
ARDX
ARDELYX, INC.
SALE10b5-1
10b5-1 plan
7,500$6.72$50.4K1,270,273May 29, 2024May 31, 2024 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
31,484$7.81$245.9K1,277,773May 21, 2024May 23, 2024 ↗View →
ARDX
ARDELYX, INC.
SALE10b5-1
10b5-1 plan
3,000$7.99$24.0K1,307,933May 14, 2024May 15, 2024 ↗View →
ARDX
ARDELYX, INC.
PURCHASE
President & CEO
30,000$0.99$29.7K1,340,933Apr 29, 2024May 1, 2024 ↗View →
ARDX
ARDELYX, INC.
SALE10b5-1
10b5-1 plan
30,000$6.40$192.1K1,310,933Apr 29, 2024May 1, 2024 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
30,000——670,000Apr 29, 2024May 1, 2024 ↗View →
ARDX
ARDELYX, INC.
SALE10b5-1
10b5-1 plan
7,500$7.06$52.9K1,310,933Apr 15, 2024Apr 17, 2024 ↗View →
ARDX
ARDELYX, INC.
SALE10b5-1
10b5-1 plan
1,518$7.31$11.1K1,318,433Apr 1, 2024Apr 2, 2024 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
SALE
15,000——0Mar 5, 2024Mar 6, 2024 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
PURCHASE
15,000$2.80$42.0K83,596Mar 5, 2024Mar 6, 2024 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
22,917$8.75$200.4K1,319,951Feb 20, 2024Feb 22, 2024 ↗View →
ARDX
ARDELYX, INC.
PURCHASEGRANT
Stock grant
605,904——605,904Jan 16, 2024Jan 18, 2024 ↗View →
ARDX
ARDELYX, INC.
PURCHASEGRANT
Stock grant
475,000——1,342,868Jan 16, 2024Jan 18, 2024 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
11,368$4.36$49.6K867,868Nov 20, 2023Nov 22, 2023 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
11,419$3.55$40.6K876,236Aug 21, 2023Aug 23, 2023 ↗View →
TPST
TEMPEST THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
8,200——8,200Jun 15, 2023Jun 20, 2023 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
30,474——30,474Jun 8, 2023Jun 12, 2023 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
8,584——68,596Jun 8, 2023Jun 12, 2023 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
11,357$3.65$41.5K887,655May 23, 2023May 24, 2023 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
SALE
4,408$11.33$49.9K60,012Mar 17, 2023Mar 21, 2023 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
PURCHASE
15,000$3.32$49.8K64,420Mar 17, 2023Mar 21, 2023 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
SALE
15,000——0Mar 17, 2023Mar 21, 2023 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
13,449$3.00$40.4K896,012Feb 21, 2023Feb 24, 2023 ↗View →
ARDX
ARDELYX, INC.
PURCHASEGRANT
Stock grant
1,124,000——1,124,000Jan 5, 2023Jan 6, 2023 ↗View →
ARDX
ARDELYX, INC.
PURCHASEGRANT
Stock grant
250,000——909,461Jan 5, 2023Jan 6, 2023 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
121$1.94$235665,397Nov 22, 2022Nov 23, 2022 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
162$1.94$314665,518Nov 22, 2022Nov 23, 2022 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
5,936$1.95$11.6K659,461Nov 22, 2022Nov 23, 2022 ↗View →
ARDX
ARDELYX, INC.
PURCHASE
President & CEO
3,000$0.62$1.9K665,680Aug 31, 2022Sep 1, 2022 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
54$0.98$53662,756Aug 22, 2022Aug 24, 2022 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
6,016$0.98$5.9K662,810Aug 22, 2022Aug 24, 2022 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
76$0.98$74662,680Aug 22, 2022Aug 24, 2022 ↗View →
TPST
TEMPEST THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
3,500——3,500Jun 17, 2022Jun 22, 2022 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
12,671——49,420Jun 9, 2022Jun 10, 2022 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
45,423——45,423Jun 9, 2022Jun 10, 2022 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
2,144$0.64$1.4K668,826Jun 6, 2022Jun 8, 2022 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
101,480$0.65$66.1K670,970Jun 6, 2022Jun 8, 2022 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
6,124$0.67$4.1K772,450May 20, 2022May 23, 2022 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
SALE
15,000——0May 2, 2022May 4, 2022 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
PURCHASE
15,000$4.79$71.8K51,749May 2, 2022May 4, 2022 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
SALE
15,000$6.99$104.9K36,749May 2, 2022May 4, 2022 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
6,229$0.67$4.2K775,574Feb 22, 2022Feb 25, 2022 ↗View →
ARDX
ARDELYX, INC.
PURCHASEGRANT
Stock grant
150,000——781,803Jan 6, 2022Jan 12, 2022 ↗View →
ARDX
ARDELYX, INC.
PURCHASEGRANT
Stock grant
700,000——700,000Jan 6, 2022Jan 12, 2022 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
2,607$0.99$2.6K631,803Nov 22, 2021Nov 24, 2021 ↗View →
ARDX
ARDELYX, INC.
PURCHASEGRANT
Stock grant
300,000——634,410Oct 8, 2021Oct 29, 2021 ↗View →
TPST
TEMPEST THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
6,635——6,635Sep 21, 2021Sep 23, 2021 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
2,573$1.32$3.4K329,730Aug 20, 2021Aug 24, 2021 ↗View →
ARDX
ARDELYX, INC.
PURCHASE
President & CEO
267,892$0.54$144.7K482,646Aug 3, 2021Aug 5, 2021 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
267,892——0Aug 3, 2021Aug 5, 2021 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
150,343$1.64$246.6K332,303Aug 3, 2021Aug 5, 2021 ↗View →
TPST
TEMPEST THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
4,830——4,830Jun 25, 2021Jun 29, 2021 ↗View →
TPST
TEMPEST THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
16,784——16,784Jun 25, 2021Jun 29, 2021 ↗View →
TPST
TEMPEST THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
9,660——9,660Jun 25, 2021Jun 29, 2021 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
36,111——36,111Jun 10, 2021Jun 14, 2021 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
10,115——36,749Jun 10, 2021Jun 14, 2021 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
2,534$7.09$18.0K214,754May 20, 2021May 21, 2021 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
SALE
5,634——0May 18, 2021May 20, 2021 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
PURCHASE
5,634$7.56$42.6K26,634May 18, 2021May 20, 2021 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
2,534$6.88$17.4K217,288Feb 22, 2021Feb 24, 2021 ↗View →
ARDX
ARDELYX, INC.
PURCHASEGRANT
Stock grant
517,959——517,959Jan 5, 2021Jan 7, 2021 ↗View →
ARDX
ARDELYX, INC.
PURCHASEGRANT
Stock grant
115,102——219,822Jan 5, 2021Jan 7, 2021 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
106,337$5.61$596.3K104,720Sep 15, 2020Sep 17, 2020 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
23,128$7.01$162.1K24,364Jul 2, 2020Jul 6, 2020 ↗View →
ARDX
ARDELYX, INC.
PURCHASE
President & CEO
1,235——47,492Jun 10, 2020Jun 12, 2020 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,855——21,000Jun 4, 2020Jun 8, 2020 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
18,574——18,574Jun 4, 2020Jun 8, 2020 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
23,128$7.33$169.6K46,257Jun 1, 2020Jun 2, 2020 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
SALE
5,000$12.65$63.3K15,145Jun 1, 2020Jun 3, 2020 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
PURCHASE
5,000$2.81$14.1K20,145Jun 1, 2020Jun 3, 2020 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
SALE
5,000——0Jun 1, 2020Jun 3, 2020 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
4,486$7.03$31.5K69,385May 5, 2020May 5, 2020 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
15,941$7.01$111.7K73,871May 4, 2020May 5, 2020 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
9,428$7.02$66.2K89,812Apr 17, 2020Apr 17, 2020 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
10,500$7.01$73.6K99,240Apr 16, 2020Apr 17, 2020 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
500$7.03$3.5K109,740Apr 15, 2020Apr 17, 2020 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
11,123——0Mar 2, 2020Mar 4, 2020 ↗View →
ARDX
ARDELYX, INC.
PURCHASE
President & CEO
11,123$1.08$12.0K219,180Mar 2, 2020Mar 4, 2020 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
11,123$7.00$77.9K208,057Mar 2, 2020Mar 4, 2020 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
20,428$7.01$143.3K110,240Mar 2, 2020Mar 4, 2020 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
25,000——11,123Feb 5, 2020Feb 7, 2020 ↗View →
ARDX
ARDELYX, INC.
SALE
President & CEO
25,000$7.32$182.9K206,828Feb 5, 2020Feb 7, 2020 ↗View →
ARDX
ARDELYX, INC.
PURCHASE
President & CEO
25,000$1.08$27.0K231,828Feb 5, 2020Feb 7, 2020 ↗View →
ARDX
ARDELYX, INC.
PURCHASEGRANT
Stock grant
557,460——557,460Jan 9, 2020Jan 13, 2020 ↗View →
Other insiders · FOLD
Loading peer insiders…
About this filer
CIK 0001321402
ROLE
Director
PRIMARY
FOLD
COMPANIES
3
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001321402DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback